Holen Sie sich die Stockscreener-App
72.68
5.01%
-4.039
Schlusskurs vom Vortag:
$76.72
Offen:
$76.51
24-Stunden-Volumen:
4.01M
Relative Volume:
0.46
Marktkapitalisierung:
$12.08B
Einnahmen:
$640.44M
Nettoeinkommen (Verlust:
$-743.28M
KGV:
-6.4383
EPS:
-11.2888
Netto-Cashflow:
$-206.93M
1W Leistung:
-18.52%
1M Leistung:
+52.98%
6M Leistung:
+1.97%
1J Leistung:
+0.00%
1-Tages-Spanne:
$72.60
$77.00
1-Wochen-Bereich:
$72.10
$91.28
52-Wochen-Spanne:
$22.89
$91.45
Tempus Ai Inc Stock (TEM) Company Profile
Firmenname
Tempus Ai Inc
Sektor
Branche
Telefon
800-976-5448
Adresse
600 WEST CHICAGO AVENUE, CHICAGO
Vergleichen Sie TEM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
72.94 | 12.08B | 640.44M | -743.28M | -206.93M | -11.29 |
|
VEEV
Veeva Systems Inc
|
227.18 | 37.14B | 2.66B | 665.91M | 1.08B | 4.05 |
|
DOCS
Doximity Inc
|
73.86 | 14.07B | 516.85M | 174.11M | 217.38M | 0.87 |
|
SOLV
Solventum Corp
|
73.77 | 12.87B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
HQY
Healthequity Inc
|
110.68 | 9.68B | 1.15B | 96.70M | -161.99M | 1.09 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Fortgesetzt | TD Cowen | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-12-09 | Eingeleitet | Guggenheim | Buy |
| 2024-11-11 | Herabstufung | Stifel | Buy → Hold |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-12 | Eingeleitet | Piper Sandler | Neutral |
| 2024-07-09 | Eingeleitet | BofA Securities | Buy |
| 2024-07-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-07-09 | Eingeleitet | Longbow | Buy |
| 2024-07-09 | Eingeleitet | Loop Capital | Buy |
| 2024-07-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-07-09 | Eingeleitet | Needham | Buy |
| 2024-07-09 | Eingeleitet | Stifel | Buy |
| 2024-07-09 | Eingeleitet | TD Cowen | Buy |
| 2024-07-09 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Tempus Ai Inc Aktie (TEM) Neueste Nachrichten
Tempus and Stemline Therapeutics, Inc., A Subsidiary of the Menarini Group, Announce Collaboration to Implement Tempus Next, an AI-Enabled Care Pathway Intelligence Platform to Support Patients with Metastatic Breast Cancer - The Manila Times
Tempus AI, Stemline collaborate to leverage Next to help clinicians - TipRanks
Why Tempus AI, Inc. (TEM) Crashed on Thursday - Insider Monkey
Top digital health funding: OpenEvidence, Abridge, Frontera - Modern Healthcare
Tempus AI (NASDAQ:TEM) Trading Up 6.8%Time to Buy? - MarketBeat
Tempus AI (TEM) Expected to Announce Earnings on Monday - MarketBeat
Tempus AI chief accounting officer sells $201,532 in stock By Investing.com - Investing.com South Africa
Tempus AI Dominates the Stock Market! A New Era in Predictive Trading? - Mi Valle
Tempus AI, Inc. (NASDAQ:TEM) CAO Sells $66,969.66 in Stock - MarketBeat
Ryan Fukushima Sells 2,868 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock - MarketBeat
Tempus AI chief accounting officer sells $201,532 in stock - Investing.com India
Tempus AI, Inc. (NASDAQ:TEM) EVP Erik Phelps Sells 61,582 Shares - MarketBeat
Insider Selling: Tempus AI, Inc. (NASDAQ:TEM) CFO Sells 31,780 Shares of Stock - MarketBeat
Tempus AI (NASDAQ:TEM) Stock Price Down 7.8%Here's Why - MarketBeat
Tempus AI chief legal officer Erik Phelps sells shares worth $5.07m - Investing.com
tempus AI EVP Andrew Polovin sells $5.3 million in stock - Investing.com
Tempus AI COO Ryan Fukushima sells $234,814 in stock - Investing.com
Tempus AI Executives Sell Shares Worth Over $14 Million - TradingView
The Tempus AI Rollercoaster: Booming Stocks, Insider Moves, and Future Prospects - Mi Valle
Tempus AI’s Tumbling Path: Unraveling the Stock’s Shocking Descent - Mi Valle
Medical Stocks To Watch TodayFebruary 20th - MarketBeat
Tempus AI (NASDAQ:TEM) Trading Down 14.5%Here's What Happened - MarketBeat
Tempus AI (NASDAQ:TEM) Shares Gap DownShould You Sell? - MarketBeat
Guru Fundamental Report for TEM - Nasdaq
10 AI News and Ratings You Should Not Miss - Insider Monkey
Why Tempus AI, Inc (TEM) is the Best Performing Healthcare Stock So Far in 2025 - Insider Monkey
Can RNA-Based AI Revolutionize Cancer Care? Tempus and Genialis Join Forces - StockTitan
Tempus AI’s Stock Soars 11%: Investment Goldmine or Hidden Risks? - Reporteros del Sur -
Why Tempus AI Took a Surprise Tumble This Week - reporterosdelsur.com.mx
10 Best Performing Healthcare Stocks So Far in 2025 - Insider Monkey
Why Tempus AI (TEM) Crashed on Tuesday? - MSN
Tempus AI Expands with Ambry Genetics and New Products: What’s Next for TEM Stock? - PUNE.NEWS
Tempus AI (NASDAQ:TEM) Trading Up 3.8%Should You Buy? - MarketBeat
Medical Stocks To ConsiderFebruary 19th - MarketBeat
What the Options Market Tells Us About Tempus AI - Benzinga
Tempus AI raises $300M in debt financing - Modern Healthcare
Tempus AI Attracts Heavy Institutional Buying, Led by JPMorgan a - GuruFocus.com
Tempus to Present at TD Cowen’s 45th Annual Health Care Conference - 01Net
Tempus AI Attracts Heavy Institutional Buying, Led by JPMorgan and ARK - Yahoo Canada Finance
Tempus AI Transforms Healthcare with AI, TEM Stock Soars - TipRanks
Can Tempus's AI Healthcare Vision Reshape Precision Medicine? CFO Takes Center Stage - StockTitan
Tempus to Present at TD Cowen's 45th Annual Health Care Conference - The Bakersfield Californian
Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Tempus AI Sees Surge In Institutional Holdings In Q4: Cathie Wood's Ark Invest, JPMorgan, And BlackRock Load Up On TEM Stock - Benzinga India
Tempus AI (NASDAQ:TEM) Shares Down 7.8%Time to Sell? - MarketBeat
Tempus AI Stock Eyes Best Rally In 5 Months Amid Pelosi-Linked Hype, But Retail’s Turning Doubtful Now - MSN
Tempus AI’s Bold Moves and the Secret Drama Unveiled Behind Insider Sales - mivalle.net.ar
Healthcare AI Leader Secures Massive $560M Financing Deal: Inside Tempus' Game-Changing Expansion - StockTitan
Is Now the Time to Buy Tempus AI Stock? Key Factors to Consider - The Africa Logistics
Tempus AI's COO Ryan Fukushima sells shares worth $2.27 million - MSN
Tempus AI Is A Buy On Dips In The AI-Driven Healthcare Sector (NASDAQ:TEM) - Seeking Alpha
Finanzdaten der Tempus Ai Inc-Aktie (TEM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.71%
2.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):